News View all news
FDA approves first epoetin alfa biosimilar for the treatment of anemia
FDA has approved epoetin alfa-epbx (Retacrit—Hospira) as a biosimilar to epoetin alfa (Epogen/Procrit—Amgen) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine for individuals with HIV.
April 24, 2018
Pharmacy’s way forward
Last weekend, representatives from APhA’s three Academies—Academy of Pharmacy Practice and Management (APhA–APPM), Academy of Pharmaceutical Research and Science (APhA–APRS), and Academy of Student…0 comments
May 8, 2018
Pharmacists to Serve on Health and Human Services (HHS) Pain Management Task Force
The Task Force will hold its inaugural public meeting on May 30, 2018, from 9:30 a.m. to 5:00 p.m. ET, and on May 31, 2018, from 9:00 a.m. to 3:30 p.m. ET.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.